[Further development of the Roehl test for testing antimalarial agents on Plasmodium cathemerium in the canary by intravenous administration].
D000818:Animals; D000830:Animals, Laboratory; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D002171:Canaries; D002738:Chloroquine / Q000627:therapeutic use; D007275:Injections, Intravenous; D008289:Malaria, Avian / Q000188:drug therapy*; D008722:Methods; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013424:Sulfanilamides / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D000962:Antimalarials; D013424:Sulfanilamides; D013449:Sulfonamides; D013411:Sulfadiazine; D002738:Chloroquine; D011803:Quinine; D011319:Primaquine; D002727:Proguanil; D011739:Pyrimethamine
Ein Weiterentwicklung des Roehl-Test zur Prüfung bon Malariamitteln an Plasmodium cathemerium beim Kanarienvogel durch intravenöse Verabreichung.